APA (7th ed.) Citation

MO, A., RC, B., A, I., L, T., MC, T., FC, B., . . . R, B. (2026). Treatment patterns and safety of adjuvant therapy after chemoimmunotherapy for early-stage triple-negative breast cancer: Real-world data from the Neo-Real/GBECAM 0123 study. Breast cancer research and treatment, 216(3), . https://doi.org/10.1007/s10549-026-07938-0

Chicago Style (17th ed.) Citation

MO, Andrade, et al. "Treatment Patterns and Safety of Adjuvant Therapy After Chemoimmunotherapy for Early-stage Triple-negative Breast Cancer: Real-world Data from the Neo-Real/GBECAM 0123 Study." Breast Cancer Research and Treatment 216, no. 3 (2026). https://doi.org/10.1007/s10549-026-07938-0.

MLA (9th ed.) Citation

MO, Andrade, et al. "Treatment Patterns and Safety of Adjuvant Therapy After Chemoimmunotherapy for Early-stage Triple-negative Breast Cancer: Real-world Data from the Neo-Real/GBECAM 0123 Study." Breast Cancer Research and Treatment, vol. 216, no. 3, 2026, https://doi.org/10.1007/s10549-026-07938-0.